gabexate and famotidine

gabexate has been researched along with famotidine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaen, H; Eguchi, F; Fukami, T; Imura, H; Sudou, K1
Ashizawa, N; Hashimoto, T; Imaoka, T; Kinoshita, Y; Miyake, T; Shizuku, T1
Chen, JZ; Kong, J; Li, ZS; Shi, G; Wang, W; Wu, SD; Zhang, XB1
Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA1

Trials

2 trial(s) available for gabexate and famotidine

ArticleYear
Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
    Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:4

    Topics: Anti-Ulcer Agents; Dyspepsia; Esters; Famotidine; Female; Gabexate; Guanidines; Humans; Japan; Male; Middle Aged; Treatment Outcome; Trypsin Inhibitors

2006
Choledochoscope manometry about different drugs on the Sphincter of Oddi.
    World journal of gastroenterology, 2008, Oct-14, Volume: 14, Issue:38

    Topics: Adult; Aged; Aged, 80 and over; Benzamides; Cholecystectomy; Cimetidine; Domperidone; Endoscopes; Famotidine; Female; Gabexate; Gastrointestinal Agents; Glycoproteins; Histamine H2 Antagonists; Humans; Male; Manometry; Middle Aged; Morpholines; Muscle Contraction; Pressure; Serine Proteinase Inhibitors; Sphincter of Oddi; Young Adult

2008

Other Studies

2 other study(ies) available for gabexate and famotidine

ArticleYear
Acute pancreatitis occurring in the early postpartum period: a case report.
    Journal of perinatal medicine, 2003, Volume: 31, Issue:4

    Topics: Abdominal Pain; Acute Disease; Adolescent; Back Pain; Famotidine; Female; Gabexate; Histamine H2 Antagonists; Humans; Nausea; Pancreatitis; Pregnancy; Puerperal Disorders; Serine Proteinase Inhibitors; Tomography, X-Ray Computed; Treatment Outcome; Vomiting

2003
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
    Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3

    Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs

2013